At-Home Lecanemab Injections Side Effects: What Dementia Caregivers Should Watch For

Learn the ARIA warning signs, MRI schedule, and injection reactions to watch during at-home lecanemab.

At-home lecanemab injections can cause brain swelling and bleeding, called ARIA, plus local skin reactions and brief flu-like symptoms. Caregivers should watch for headache, confusion, dizziness, vision changes, nausea, walking problems, or stroke-like weakness and seek prompt evaluation. Lecanemab is an antibody drug that clears amyloid-beta, a protein that builds up in early Alzheimer's disease. According to the FDA, the agency approved once-weekly subcutaneous Leqembi Iqlik as a starting dose for early Alzheimer's on July 13, 2026, with at-home use after supervised training, as described in the FDA approval notice.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

Table of Contents

Why is ARIA the main risk?

ARIA means amyloid-related imaging abnormalities. ARIA-E is fluid and swelling in the brain. ARIA-H is tiny bleeds and iron deposits from leaky vessels.

The drug label carries a boxed warning because ARIA can become serious or fatal. That warning includes bleeding inside the brain larger than 1 cm. According to FDA prescribing information, details appear in the DailyMed drug label.

Which symptoms need prompt evaluation?

Call the care team right away for new or worsening brain symptoms. Do not wait to see if they fade on their own. According to Eisai prescribing information, caregivers should seek prompt evaluation for:.

  • headache
  • confusion
  • dizziness
  • vision changes
  • nausea

Why keep MRI visits when your loved one feels fine?

ARIA often causes no symptoms. It is usually found only on MRI. A calm week at home does not rule it out.

Monitoring starts with a baseline brain MRI. Follow-up scans occur after about 1, 2, 3, and 6 months. Doctors pause, continue, or stop dosing based on ARIA type, severity, and symptoms.

Who faces higher risk, and what do injection reactions look like?

People with two copies of the ApoE e4 gene face higher rates of symptomatic, serious, and severe ARIA. Doctors recommend ApoE e4 testing and risk counseling before treatment begins. Local reactions are more common but less dangerous.

According to Eisai and Biogen, about 11% of people using the 360-mg weekly autoinjector had mild-to-moderate redness, swelling, or itching, while under 1% had headache, fever, or fatigue, as reported in the companies' maintenance-dosing announcement. Those local reactions did not prevent continued dosing. Keep a dated note of skin changes, fevers, headaches, falls, and missed or delayed doses to review at each visit.


You Might Also Like

HelpDementia.com

Dementia, Alzheimer's, Caregiving & Healthy Aging Guidance

© 2026 HelpDementia.com. All rights reserved.

Educational information only. It is not medical advice and does not replace care from a qualified clinician.